# Burning Rock Biotech Limited (BNR)

Source: https://www.quantisnow.com/company/BNR
Generated: 2026-11-14T19:57:24.421Z

- Ticker: BNR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2020
- SEC CIK: 0001792267
- Website: brbiotech.com

## About

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass IO, the corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. The company also offers LungCore for lung cancer, ProstrateCore for prostrate cancer, BreastCore for breast cancer, LymphPlasma for lymphomas, and ThyroCare for thyroid cancer. In addition, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. Burning Rock Biotech Limited has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, Sino Biopharm, CStone and BeiGene. The company was founded in 2014 and is headquartered in Guangzhou, China.

## Latest BNR news and filings

- 2026-09-10 11:17 UTC [Burning Rock Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-second-quarter-2026-financial-results-6710813)
- 2026-09-10 11:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6710797)
- 2026-07-02 12:30 UTC [Insider Buy] [Director Han Yusheng bought $6,182,172 worth of Ordinary Shares (731,410 units at $8.45), increasing direct ownership by 4% to 18,404,086 units (SEC Form 4)](https://www.quantisnow.com/insight/director-han-yusheng-bought-6182172-worth-of-ordinary-shares-731410-6624345)
- 2026-07-02 11:19 UTC [Burning Rock Announces Founder’s Purchase of Its ADSs](https://www.quantisnow.com/insight/burning-rock-announces-founders-purchase-of-its-adss-6624156)
- 2026-06-09 10:38 UTC [Burning Rock Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-first-quarter-2026-financial-results-6594412)
- 2026-06-09 10:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6594373)
- 2026-05-13 21:12 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-burning-rock-biotech-6551626)
- 2026-04-28 10:45 UTC [Burning Rock Publishes 2025 Annual Report on Form 20-F](https://www.quantisnow.com/insight/burning-rock-publishes-2025-annual-report-on-form-20-f-6517414)
- 2026-04-28 10:08 UTC [SEC Form 20-F filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-burning-rock-biotech-limited-6517342)
- 2026-04-02 11:17 UTC [SEC Form 4] [SEC Form 4 filed by Han Yusheng](https://www.quantisnow.com/insight/sec-form-4-filed-by-han-yusheng-6483308)
- 2026-04-02 10:25 UTC [Burning Rock Announces Founder's Purchase of Its ADSs](https://www.quantisnow.com/insight/burning-rock-announces-founders-purchase-of-its-adss-6483181)
- 2026-03-19 00:17 UTC [SEC Form 3] [SEC Form 3 filed by new insider Deng Feng](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-deng-feng-6459955)
- 2026-03-17 14:10 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hayes Wendy W.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hayes-wendy-w-6451617)
- 2026-03-17 14:08 UTC [SEC Form 3] [New insider Han Yusheng claimed ownership of 17,357,806 units of Ordinary Shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-han-yusheng-claimed-ownership-of-17357806-units-of-6451615)
- 2026-03-17 14:00 UTC [SEC Form 3] [New insider Zhang Zhihong claimed ownership of 1,061,990 units of Ordinary Shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-zhang-zhihong-claimed-ownership-of-1061990-units-of-6451609)
- 2026-03-17 13:50 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hu Xiaozhi](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hu-xiaozhi-6451590)
- 2026-03-17 13:45 UTC [SEC Form 3] [New insider Xu Licen Lisa claimed ownership of 22,718 units of Ordinary Shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-xu-licen-lisa-claimed-ownership-of-22718-units-6451584)
- 2026-03-13 00:58 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6445941)
- 2026-03-12 11:08 UTC [Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-unaudited-fourth-quarter-and-full-year-2025-6443390)
- 2026-01-05 06:16 UTC [Burning Rock Announces Founder's Purchase of Its ADSs](https://www.quantisnow.com/insight/burning-rock-announces-founders-purchase-of-its-adss-6332862)
- 2025-12-23 11:11 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6326115)
- 2025-12-23 04:04 UTC [Leadership Update] [Burning Rock Announces Results of 2025 Annual General Meeting](https://www.quantisnow.com/insight/burning-rock-announces-results-of-2025-annual-general-meeting-6326043)
- 2025-12-19 23:00 UTC [SEC Form SCHEDULE 13G filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-burning-rock-biotech-limited-6324352)
- 2025-12-01 14:56 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6297266)
- 2025-12-01 09:11 UTC [Leadership Update] [Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025](https://www.quantisnow.com/insight/burning-rock-announces-2025-annual-general-meeting-to-be-held-6296627)
- 2025-11-20 11:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6287859)
- 2025-11-20 06:52 UTC [Burning Rock Reports Third Quarter 2025 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-third-quarter-2025-financial-results-6287764)
- 2025-09-24 06:42 UTC [Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer](https://www.quantisnow.com/insight/burning-rocks-oncoguide-oncoscreen-plus-cdx-system-now-approved-in-6209842)
- 2025-09-08 10:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6192356)
- 2025-09-08 05:39 UTC [Burning Rock Reports Second Quarter 2025 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-second-quarter-2025-financial-results-6192273)
- 2025-06-06 10:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-6075468)
- 2025-06-06 07:31 UTC [Burning Rock Reports First Quarter 2025 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-first-quarter-2025-financial-results-6075389)
- 2025-04-29 10:31 UTC [SEC Form 20-F filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-burning-rock-biotech-limited-6005823)
- 2025-03-25 12:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-5958751)
- 2025-03-25 11:45 UTC [Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-unaudited-fourth-quarter-and-full-year-2024-5958640)
- 2024-12-31 11:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-5827415)
- 2024-12-31 09:56 UTC [Leadership Update] [Burning Rock Announces Results of 2024 Annual General Meeting](https://www.quantisnow.com/insight/burning-rock-announces-results-of-2024-annual-general-meeting-5827319)
- 2024-12-04 11:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-5799316)
- 2024-12-04 04:59 UTC [Burning Rock Reports Third Quarter 2024 Financial Results](https://www.quantisnow.com/insight/burning-rock-reports-third-quarter-2024-financial-results-5799244)
- 2024-12-03 21:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Burning Rock Biotech Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-burning-rock-biotech-limited-5797877)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BNR
- Earnings history: https://www.quantisnow.com/earnings/BNR
- Dividend history: https://www.quantisnow.com/dividends/BNR
- Insider transactions: https://www.quantisnow.com/insiders/BNR
- Options chain: https://www.quantisnow.com/options/BNR
- SEC 8-K filings only: https://www.quantisnow.com/company/BNR/8-k
- RSS and alerts for BNR: https://www.quantisnow.com/docs/rss-feeds.md